Page last updated: 2024-08-17

propane and daunorubicin

propane has been researched along with daunorubicin in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chadwick, DP; Herman, EH; Mhatre, RM	1
Woodman, RJ	1

Other Studies

2 other study(ies) available for propane and daunorubicin

Article	Year
Modification of some of the toxic effects of daunomycin (NSC-82,151) by pretreatment with the antineoplastic agent ICRF 159 (NSC-129,943). Toxicology and applied pharmacology, 1974, Volume: 27, Issue:3 Topics: Animals; Antineoplastic Agents; Arrhythmias, Cardiac; Blood Glucose; Chromatography, Paper; Cricetinae; Daunorubicin; Electrocardiography; Enzymes; Haplorhini; Kidney; Liver; Lung; Macaca; Male; Myocardium; Piperazines; Propane; Spectrometry, Fluorescence; Spleen; Time Factors	1974
Enhancement of antitumor effectiveness of ICRF-159 (NSC-129943) against early L1210 leukemia by combination with cis-diamminedichloroplatinum (NSC-119875) or daunomycin (NSC-82151). Cancer chemotherapy reports. Part 2, 1974, Volume: 4, Issue:1 Topics: Administration, Oral; Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Cisplatin; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Drug Therapy, Combination; Injections, Intraperitoneal; Injections, Intravenous; Injections, Subcutaneous; Leukemia L1210; Mice; Piperazines; Propane	1974

Article

Year

Modification of some of the toxic effects of daunomycin (NSC-82,151) by pretreatment with the antineoplastic agent ICRF 159 (NSC-129,943).

Toxicology and applied pharmacology, 1974, Volume: 27, Issue:3

Topics: Animals; Antineoplastic Agents; Arrhythmias, Cardiac; Blood Glucose; Chromatography, Paper; Cricetinae; Daunorubicin; Electrocardiography; Enzymes; Haplorhini; Kidney; Liver; Lung; Macaca; Male; Myocardium; Piperazines; Propane; Spectrometry, Fluorescence; Spleen; Time Factors

1974

Enhancement of antitumor effectiveness of ICRF-159 (NSC-129943) against early L1210 leukemia by combination with cis-diamminedichloroplatinum (NSC-119875) or daunomycin (NSC-82151).

Cancer chemotherapy reports. Part 2, 1974, Volume: 4, Issue:1

Topics: Administration, Oral; Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Cisplatin; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Drug Therapy, Combination; Injections, Intraperitoneal; Injections, Intravenous; Injections, Subcutaneous; Leukemia L1210; Mice; Piperazines; Propane

1974